PubMed ID:
19092152
Public Release Type:
Journal
Publication Year: 2008
Affiliation: Department of Urology, Queen's University, Kingston, ON, Canada. jcn@queensu.ca
DOI:
https://doi.org/10.1056/NEJMoa0803240
Authors:
Wang Y,
Alexander RB,
Anderson RU,
Ardern D,
Bale R Jr,
Barrell E,
Berger R,
Braverman A,
Butler L,
Byrd G,
Calhoun EA,
Cen L,
Chai T,
Chan C,
Cheah PY,
Chew A,
Chin LT,
Chronic Prostatitis Collaborative Research Network,
Chuai S,
Clark-Pereira J,
Clemens JQ,
Datta NS,
Desai P,
Dobi C,
Downey J,
Duncan W,
Durborow M,
Fitzgerald CM,
Flores V,
Fowler JE Jr,
Freeman S,
Frest M,
Giesler J,
Heng HK,
Hennenfent M,
Kahn N,
Keay S,
Kohr T,
Krieger JN,
Kusek JW,
Lamarr N,
Landis JR,
Lang DC,
Lee SW,
Leong WS,
Liong ML,
Litwin MS,
Loong CW,
Lumpkin D,
Madigan R,
Marko D,
Markowitz-Chrystal G,
McNaughton-Collins M,
Mervin K,
Mickelberg K,
Mohan M,
Morales A,
Morey A,
Muller C,
Mullins C,
Murphy D,
Murray J,
Nadler R,
Nickel JC,
Nyberg LM,
O'Leary M,
Orenberg E,
Payne CK,
Pontari M,
Potts J,
Propert KJ,
Radebaugh L,
Rhodes D,
Riley D,
Ross S,
Rothman I,
Santiago M,
Schaeffer AJ,
Seng LW,
Shinghal R,
Shoskes DA,
Siemens R,
Simpkiss B,
Sin LC,
Sweet R,
Tapley R,
Tripp DA,
Turner J,
Underwood Y,
White PC,
Williams C,
Xie Y,
Yang JR,
Yap HW,
Yuen KH,
Zeitlin S
Studies:
Chronic Prostatitis Collaborative Research Network
In men with chronic prostatitis-chronic pelvic pain syndrome, treatment with alpha-adrenergic receptor blockers early in the course of the disorder has been reported to be effective in some, but not all, relatively small randomized trials.